Q2 2017

Filed Aug 18, 2017 · 10-Q · 49 days after period end · 0001654954-17-007742

Q2 2017 · 10-Q

Revenue

$87.00K

no prior Q2 2016 on file

Net Income

-$1.07M

N/M vs Q2 2016

EPS Diluted

-$0.59

N/M vs Q2 2016

Gross Profit$5,000−94.8%

Operating Income

Same quarter

Metric	Q2 2017	Q2 2016	Q2 2015	Q2 2014
Revenue	$87.00K	—	$10.00K	$11.00K
Net Income	-$1.07M	-$1.88M	-$1.71M	-$2.15M
EPS Diluted	-$0.59	-$52.95	-$0.03	-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR